9.52
-0.03
(-0.31%)
At close: April 17 at 4:00:02 PM EDT
9.52
0.00
(0.00%)
After hours: April 17 at 4:07:51 PM EDT
Research Analysis
Earnings Estimate
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | 5 | 5 | 4 | 5 |
Avg. Estimate | 0.19 | 0.19 | 0.75 | 0.87 |
Low Estimate | 0.16 | 0.16 | 0.64 | 0.7 |
High Estimate | 0.21 | 0.21 | 0.81 | 1.02 |
Year Ago EPS | 0.22 | 0.2 | 0.53 | 0.75 |
Revenue Estimate
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | 5 | 5 | 5 | 5 |
Avg. Estimate | 443.91M | 446.6M | 1.79B | 1.87B |
Low Estimate | 442.7M | 444.23M | 1.78B | 1.84B |
High Estimate | 445.13M | 448.3M | 1.8B | 1.89B |
Year Ago Sales | 423.43M | 426.29M | 1.72B | 1.79B |
Sales Growth (year/est) | 4.84% | 4.76% | 4.44% | 4.15% |
Earnings History
Currency in USD | 3/31/2024 | 6/30/2024 | 9/30/2024 | 12/31/2024 |
---|---|---|---|---|
EPS Est. | 0.19 | 0.2 | 0.2 | 0.2 |
EPS Actual | 0.22 | 0.2 | 0.19 | 0.16 |
Difference | 0.03 | 0 | -0.01 | -0.04 |
Surprise % | 16.35% | 1.26% | -4.00% | -18.32% |
EPS Trend
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Current Estimate | 0.19 | 0.19 | 0.75 | 0.87 |
7 Days Ago | 0.18 | 0.19 | 0.74 | 0.86 |
30 Days Ago | 0.18 | 0.19 | 0.72 | 0.87 |
60 Days Ago | 0.21 | 0.21 | 0.85 | 0.95 |
90 Days Ago | 0.21 | 0.21 | 0.85 | 0.95 |
EPS Revisions
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Up Last 7 Days | -- | -- | -- | 1 |
Up Last 30 Days | -- | -- | -- | 1 |
Down Last 7 Days | 3 | 3 | 4 | 1 |
Down Last 30 Days | 3 | 3 | 4 | 1 |
Growth Estimates
Current Qtr. | Next Qtr. | Current Year | Next Year | |
---|---|---|---|---|
HCSG | -14.75% | -4.66% | 41.59% | 15.27% |
S&P 500 | 7.04% | 5.20% | 8.89% | 14.14% |
Upgrades & Downgrades
Reiterates | Benchmark: Buy to Buy | 12/19/2024 |
Initiated | Macquarie: Neutral | 12/16/2024 |
Reiterates | Benchmark: Buy to Buy | 10/24/2024 |
Maintains | Baird: Neutral to Neutral | 10/24/2024 |
Reiterates | Benchmark: Buy to Buy | 7/25/2024 |
Maintains | RBC Capital: Outperform to Outperform | 7/25/2024 |
Related Tickers
PNTG The Pennant Group, Inc.
26.13
-0.27%
GRDN Guardian Pharmacy Services, Inc.
24.11
+2.51%
SNDA Sonida Senior Living, Inc.
21.40
-1.61%
CCRN Cross Country Healthcare, Inc.
14.26
-0.07%
LFST LifeStance Health Group, Inc.
6.70
-0.15%
CON Concentra Group Holdings Parent, Inc.
20.39
-0.83%
EHAB Enhabit, Inc.
7.68
-0.26%
MD Pediatrix Medical Group, Inc.
12.82
-2.44%
CHE Chemed Corporation
581.69
+0.06%
SGRY Surgery Partners, Inc.
21.22
+0.62%